This article first appeared in The Edge Malaysia Weekly on August 23, 2021 - August 29, 2021

Pharmaniaga Bhd, which packages and distributes Covid-19 vaccine Sinovac, is seeking approval for the vaccine to be administered to the Malaysian adolescent population.

Pfizer Inc and BioNTech SE have submitted early-stage data to US regulators showing that a third dose of their Covid-19 vaccine led to higher levels of protective antibodies.

Australia has purchased about one million doses of Pfizer’s Covid-19 vaccine from Poland to add to its inoculation efforts amid record new infections.

Taiwan has rejected an application for the emergency use of UBI Pharma’s Covid-19 vaccine candidate, although President Tsai Ing-wen said she would get a separate domestic shot in a show of support for the scheme.

Covid-19 vaccine recipients in Malaysia will not be allowed to enter Hong Kong from Aug 20 after the territory added 15 more countries, including Malaysia, to its “high risk” list.

Malaysia received 200,000 doses of the CanSino Covid-19 vaccine last Friday, the first delivery out of 3.5 million doses ordered from CanSino Biologics.

US health officials are investigating reports that Moderna Inc’s Covid-19 vaccine may be linked to a higher risk of a rare heart condition in younger adults than previously thought, The Washington Post reported, citing people familiar with the review.

Save by subscribing to us for your print and/or digital copy.

P/S: The Edge is also available on Apple's AppStore and Androids' Google Play.